PQ 273
273. Deputy Naoise Ó Cearúil asked the Minister for Health whether consideration will be given, as part of the ongoing review of medicines reimbursement, to strengthen and formalise the role of the Rare Disease Technology Review Committee; whether she will consider ensuring its early, consistent and structured involvement alongside the health technology assessment process in order to improve timely access to orphan medicines; and if she will make a statement on the matter. [48037/26]
Introduced
24 June 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
24 June 2026
Summary
273. Deputy Naoise Ó Cearúil asked the Minister for Health whether consideration will be given, as part of the ongoing review of medicines reimbursement, to strengthen and formalise the role of the Rare Disease Technology Review Committee; whether she will consider ensuring its early, consistent and structured involvement alongside the health technology assessment process in order to improve timely access to orphan medicines; and if she will make a statement on the matter. [48037/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 24 June 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-06-24/273/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-06-24/pq_273